Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 50043310
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439157(CHEMBL2418752)
Affinity DataIC50: 5.60nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439161(CHEMBL2418746)
Affinity DataIC50: 6nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439162(CHEMBL2418763)
Affinity DataIC50: 6nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439158(CHEMBL2418749)
Affinity DataIC50: 26nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439164(CHEMBL2418759)
Affinity DataIC50: 28nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439154(CHEMBL2418761)
Affinity DataIC50: 29nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439155(CHEMBL2418754)
Affinity DataIC50: 30nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439160(CHEMBL2418747)
Affinity DataIC50: 31nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439168(CHEMBL2418755)
Affinity DataIC50: 32nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439163(CHEMBL2418760)
Affinity DataIC50: 41nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439159(CHEMBL2418748)
Affinity DataIC50: 63nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439156(CHEMBL2418753)
Affinity DataIC50: 70nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439165(CHEMBL2418758)
Affinity DataIC50: 70nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439153(CHEMBL2418762)
Affinity DataIC50: 84nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439169(CHEMBL2418751)
Affinity DataIC50: 85nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439170(CHEMBL2418750)
Affinity DataIC50: 90nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439166(CHEMBL2418757)
Affinity DataIC50: 98nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439157(CHEMBL2418752)
Affinity DataIC50: 139nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439157(CHEMBL2418752)
Affinity DataIC50: 220nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439167(CHEMBL2418756)
Affinity DataIC50: 247nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439154(CHEMBL2418761)
Affinity DataIC50: 900nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439155(CHEMBL2418754)
Affinity DataIC50: 986nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439153(CHEMBL2418762)
Affinity DataIC50: 986nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439154(CHEMBL2418761)
Affinity DataIC50: 1.59E+3nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439156(CHEMBL2418753)
Affinity DataIC50: 3.01E+3nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439155(CHEMBL2418754)
Affinity DataIC50: 3.12E+3nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439153(CHEMBL2418762)
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetALK tyrosine kinase receptor(Human)
Aurigene Discovery Technologies

Curated by ChEMBL
LigandPNGBDBM50439156(CHEMBL2418753)
Affinity DataIC50: 3.91E+3nMAssay Description:Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed